ABSTRACT
Epilepsy is the most commonly encountered neurologic disorder during pregnancy. A majority of women with epilepsy continue antiepileptic drug regimens during pregnancy. To provide evidence-based care to women with epilepsy, it is critical that healthcare providers possess a basic knowledge of seizures, antiepileptic medications, and interventions specific to this patient population, as well as an understanding of the patient's basic needs and concerns. This article provides a discussion of seizure types, common antiepileptic medications, and provides evidence-based interventions related to the fetus and the mother during preconception, intrapartum, and postpartum periods.
Subject(s)
Anticonvulsants/therapeutic use , Epilepsy/drug therapy , Fetal Diseases/prevention & control , Pregnancy Complications/drug therapy , Pregnancy Outcome , Epilepsy/diagnosis , Epilepsy/epidemiology , Evidence-Based Medicine , Female , Humans , Incidence , Infant, Newborn , Infant, Newborn, Diseases/prevention & control , Postnatal Care/methods , Pregnancy , Pregnancy Complications/diagnosis , Pregnancy Complications/epidemiology , Pregnancy, High-Risk , Prenatal Care/methods , Prognosis , Risk Assessment , Severity of Illness Index , Treatment OutcomeABSTRACT
Following an analysis of the literature, this article reviews the current practices, guidelines, and recommendations for electronic fetal monitoring of the preterm fetus. The physiologic aspects of fetal heart rate control, electronic fetal monitor parameters, and differences between the preterm and term fetus are discussed. Clearly identified is the need for clinical research regarding electronic fetal monitoring of the preterm fetus to establish evidence-based practice guidelines.
